Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced CancersBusiness Wire • 06/02/25
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEMAccesswire • 06/01/25
Fraud Investigation Opened: Levi & Korsinsky Investigates Tempus AI, Inc. (TEM) on Behalf of ShareholdersAccesswire • 06/01/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Stockholders to Learn More About the InvestigationAccesswire • 06/01/25
TEM ALERT: Ongoing Investigation Into Tempus AI, Inc. - Contact Levi & KorsinskyAccesswire • 05/31/25
ROSEN, LEADING INVESTOR COUNSEL, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEMAccesswire • 05/31/25
Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation ModelBusiness Wire • 05/31/25
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Tempus AI Inc. (NASDAQ: TEM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the FirmGlobeNewsWire • 05/30/25
ATTENTION TEM Shareholders: Lost Money on Tempus AI, Inc.? Contact Levi & Korsinsky About InvestigationAccesswire • 05/30/25
Bronstein, Gewirtz & Grossman, LLC Encourages Tempus AI, Inc. (TEM) Investors to Inquire about Securities InvestigationAccesswire • 05/30/25
TEM ACTIVE INVESTIGATION: Lost Money on Tempus AI, Inc.? Contact Levi & Korsinsky NowAccesswire • 05/30/25
Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual MeetingBusiness Wire • 05/30/25
Tempus Fugit, Investors Regret? Short Seller Targets AI Darling, Warns CEO Is 'Cash Out King' (UPDATED)Benzinga • 05/29/25
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Tempus AI, Inc. (TEM) And Encourages Investors to Reach OutAccesswire • 05/29/25
Tempus AI, Inc. (NASDAQ: TEM) Securities Fraud Investigation; Investors Urged to Contact Award-Winning Firm, Gibbs MuraBusiness Wire • 05/29/25
Rosen Law Firm Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation – TEMBusiness Wire • 05/28/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Tempus AI, Inc. – TEMGlobeNewsWire • 05/28/25
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Tempus AI, Inc. (TEM) And Encourages Stockholders to Reach OutAccesswire • 05/28/25